Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Asset Utilization Ratio (2020 - 2022)

Rapid Therapeutic Science Laboratories' Asset Utilization Ratio history spans 3 years, with the latest figure at 0.0 for Q3 2022.

  • For Q3 2022, Asset Utilization Ratio rose 100.45% year-over-year to 0.0; the TTM value through Sep 2022 reached 0.0, up 100.45%, while the annual FY2021 figure was 0.0, 99.78% down from the prior year.
  • Asset Utilization Ratio for Q3 2022 was 0.0 at Rapid Therapeutic Science Laboratories, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.14 in Q2 2020 and bottomed at 0.14 in Q1 2020.
  • The 3-year median for Asset Utilization Ratio is 0.0 (2022), against an average of 0.02.
  • The largest YoY upside for Asset Utilization Ratio was 164.08% in 2021 against a maximum downside of 105.62% in 2021.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.05 in 2020, then plummeted by 99.49% to 0.0 in 2021, then tumbled by 89.93% to 0.0 in 2022.
  • Per Business Quant, the three most recent readings for RTSL's Asset Utilization Ratio are 0.0 (Q3 2022), 0.0 (Q2 2022), and 0.0 (Q1 2022).